| Product Code: ETC12122863 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel saw significant import shipments of Everolim tablets from top exporting countries including Switzerland, UK, Belgium, USA, and Germany. Despite the low concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for 2020-2024 was negative at -2.14%. Additionally, the growth rate from 2023 to 2024 also experienced a decline at -0.41%. These figures suggest a challenging market environment for Everolim tablet imports in Israel, pointing towards potential shifts in the pharmaceutical landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Everolim tablet Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Everolim tablet Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Everolim tablet Market - Industry Life Cycle |
3.4 Israel Everolim tablet Market - Porter's Five Forces |
3.5 Israel Everolim tablet Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Everolim tablet Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Israel Everolim tablet Market Revenues & Volume Share, By Therapeutic Category, 2021 & 2031F |
3.8 Israel Everolim tablet Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Everolim tablet Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Everolim tablet Market Trends |
6 Israel Everolim tablet Market, By Types |
6.1 Israel Everolim tablet Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Everolim tablet Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Israel Everolim tablet Market Revenues & Volume, By Everolim Tablets, 2021 - 2031F |
6.1.4 Israel Everolim tablet Market Revenues & Volume, By Everolim 10mg Tablets, 2021 - 2031F |
6.1.5 Israel Everolim tablet Market Revenues & Volume, By Everolim 5mg Tablets, 2021 - 2031F |
6.1.6 Israel Everolim tablet Market Revenues & Volume, By Everolim Extended Release Tablets, 2021 - 2031F |
6.2 Israel Everolim tablet Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Everolim tablet Market Revenues & Volume, By Oral Tablets, 2021 - 2031F |
6.2.3 Israel Everolim tablet Market Revenues & Volume, By 10 mg Tablets, 2021 - 2031F |
6.2.4 Israel Everolim tablet Market Revenues & Volume, By 5 mg Tablets, 2021 - 2031F |
6.2.5 Israel Everolim tablet Market Revenues & Volume, By Extended Release Form, 2021 - 2031F |
6.3 Israel Everolim tablet Market, By Therapeutic Category |
6.3.1 Overview and Analysis |
6.3.2 Israel Everolim tablet Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.3.3 Israel Everolim tablet Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Israel Everolim tablet Market Revenues & Volume, By Organ Rejection Prevention, 2021 - 2031F |
6.4 Israel Everolim tablet Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Everolim tablet Market Revenues & Volume, By Kidney and Organ Transplant Patients, 2021 - 2031F |
6.4.3 Israel Everolim tablet Market Revenues & Volume, By Transplant Recipients, 2021 - 2031F |
6.4.4 Israel Everolim tablet Market Revenues & Volume, By Patients with Autoimmune Diseases, 2021 - 2031F |
6.4.5 Israel Everolim tablet Market Revenues & Volume, By Post-transplant Patients, 2021 - 2031F |
7 Israel Everolim tablet Market Import-Export Trade Statistics |
7.1 Israel Everolim tablet Market Export to Major Countries |
7.2 Israel Everolim tablet Market Imports from Major Countries |
8 Israel Everolim tablet Market Key Performance Indicators |
9 Israel Everolim tablet Market - Opportunity Assessment |
9.1 Israel Everolim tablet Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Everolim tablet Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Israel Everolim tablet Market Opportunity Assessment, By Therapeutic Category, 2021 & 2031F |
9.4 Israel Everolim tablet Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Everolim tablet Market - Competitive Landscape |
10.1 Israel Everolim tablet Market Revenue Share, By Companies, 2024 |
10.2 Israel Everolim tablet Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here